Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study

Real-World Management of Macular Edema Secondary to Retinal Vein Occlusion with Intravitreal Aflibercept: 24-month Results from the AURIGA Observational Study

Abstract Introduction AURIGA is the largest real-world study to date to evaluate intravitreal aflibercept (IVT-AFL) treatment of diabetic macular edema or macular edema secondary to retinal vein occlusion (RVO) in routine clinical practice. Here, we report the 24-month outcomes in the RVO cohort fro...

Full description

Bibliographic Details
Main Authors: Audrey Giocanti-Aurégan, Simone Donati, Hans Hoerauf, Helmut Allmeier, Kay D. Rittenhouse, Tobias Machewitz, Chang-Hao Yang, On behalf of the AURIGA Study Investigators
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-11-01
Series:Ophthalmology and Therapy
Subjects:
Anti-vascular endothelial growth factor
Branch retinal vein occlusion
Central retinal vein occlusion
Intravitreal aflibercept
Macular edema
Observational study
Online Access:https://doi.org/10.1007/s40123-023-00830-w

Internet

https://doi.org/10.1007/s40123-023-00830-w

Similar Items